Treace Medical Concepts, Inc.

NasdaqGS:TMCI Stock Report

Market Cap: US$433.6m

Treace Medical Concepts Future Growth

Future criteria checks 0/6

Treace Medical Concepts is forecast to grow earnings and revenue by 13.5% and 8.2% per annum respectively. EPS is expected to grow by 14.7% per annum. Return on equity is forecast to be -47.7% in 3 years.

Key information

13.5%

Earnings growth rate

14.7%

EPS growth rate

Medical Equipment earnings growth16.8%
Revenue growth rate8.2%
Future return on equity-47.7%
Analyst coverage

Good

Last updated21 Dec 2024

Recent future growth updates

Recent updates

Further Upside For Treace Medical Concepts, Inc. (NASDAQ:TMCI) Shares Could Introduce Price Risks After 84% Bounce

Dec 03
Further Upside For Treace Medical Concepts, Inc. (NASDAQ:TMCI) Shares Could Introduce Price Risks After 84% Bounce

Is Treace Medical Concepts (NASDAQ:TMCI) Using Debt In A Risky Way?

Oct 26
Is Treace Medical Concepts (NASDAQ:TMCI) Using Debt In A Risky Way?

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Screens Well But There Might Be A Catch

Aug 02
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Screens Well But There Might Be A Catch

Treace Medical Concepts (NASDAQ:TMCI) Has Debt But No Earnings; Should You Worry?

Jun 28
Treace Medical Concepts (NASDAQ:TMCI) Has Debt But No Earnings; Should You Worry?

Treace Medical Concepts: Facing Increasing Competitive Pressure

Jun 14

Market Still Lacking Some Conviction On Treace Medical Concepts, Inc. (NASDAQ:TMCI)

Apr 05
Market Still Lacking Some Conviction On Treace Medical Concepts, Inc. (NASDAQ:TMCI)

Does Treace Medical Concepts (NASDAQ:TMCI) Have A Healthy Balance Sheet?

Feb 09
Does Treace Medical Concepts (NASDAQ:TMCI) Have A Healthy Balance Sheet?

Why Investors Shouldn't Be Surprised By Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) 31% Share Price Surge

Jan 04
Why Investors Shouldn't Be Surprised By Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) 31% Share Price Surge

Market Cool On Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Revenues Pushing Shares 46% Lower

Nov 11
Market Cool On Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Revenues Pushing Shares 46% Lower

Analysts Are Updating Their Treace Medical Concepts, Inc. (NASDAQ:TMCI) Estimates After Its Second-Quarter Results

Aug 13
Analysts Are Updating Their Treace Medical Concepts, Inc. (NASDAQ:TMCI) Estimates After Its Second-Quarter Results

Earnings and Revenue Growth Forecasts

NasdaqGS:TMCI - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026246-43-14-136
12/31/2025225-48-15-146
12/31/2024208-57-36-226
9/30/2024203-62-43-32N/A
6/30/2024199-64-42-30N/A
3/31/2024196-55-38-25N/A
12/31/2023187-50-46-35N/A
9/30/2023175-48-52-40N/A
6/30/2023167-42-52-38N/A
3/31/2023155-47-56-41N/A
12/31/2022142-43-45-31N/A
9/30/2022126-45-42-29N/A
6/30/2022114-39-39-31N/A
3/31/2022105-27-28-24N/A
12/31/202194-21-20-17N/A
9/30/202185-12-13-11N/A
6/30/202178-8-7-6N/A
3/31/202165-5-5-4N/A
12/31/202057-4-6-4N/A
12/31/201939-5-9-8N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: TMCI is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: TMCI is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: TMCI is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: TMCI's revenue (8.2% per year) is forecast to grow slower than the US market (9.1% per year).

High Growth Revenue: TMCI's revenue (8.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: TMCI is forecast to be unprofitable in 3 years.

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 13:08
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Treace Medical Concepts, Inc. is covered by 8 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael GormanBTIG
Robert MarcusJ.P. Morgan
Richard NewitterLeerink Partners LLC